Clinical Trial Update: Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on arginine and buphenyl for argininosuccinic aciduria, a urea cycle disorder; trial completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Argininosuccinic Aciduria
• Urea Cycle Disorder

Drugs mentioned

• Arginine (L-Arginine)
• BUPHENYL (Sodium phenylbutyrate)

Snippet

Sponsor: Brendan Lee | Conditions: Argininosuccinic Aciduria, Amino Acid Metabolism, Inborn Errors | Phase 2 | Status: COMPLETED | Results posted: 2014-11-05